Cite
HARVARD Citation
Gastinne, T. et al. (2022). Safety and antibody response after one and/or two doses of BNT162b2 Anti‐SARS‐CoV‐2 mRNA vaccine in patients treated by CAR T cells therapy. British journal of haematology. pp. 360-362. [Online].